Literature DB >> 21624763

Adalimumab desensitization after anaphylactic reaction.

Oliviero Quercia, Francesca Emiliani, Francesco Giuseppe Foschi, Giuseppe Francesco Stefanini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21624763     DOI： 10.1016/j.anai.2011.03.014

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  9 in total

Review 1.  Diagnoses and Management of Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: Reactions to Taxanes and Monoclonal Antibodies.

Authors:  Rafael Bonamichi-Santos; Mariana Castells
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 2.  Adverse reactions to biologic agents and their medical management.

Authors:  Onur Boyman; Denis Comte; François Spertini
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

3.  Desensitization to Adalimumab: An Example of Repeated Desensitization to a Biological Agent.

Authors:  Fevzi Demirel; Ozgur Kartal; Mustafa Gulec; Sait Yesillik; Abdullah Baysan; Kutay Tezel; Ugur Musabak; Osman Sener
Journal:  Drug Saf Case Rep       Date:  2015-12

4.  Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study.

Authors:  Wei-Chen Lin; Jen-Wei Chou; Hsu-Heng Yen; Wen-Hung Hsu; Hung-Hsin Lin; Jen-Kou Lin; Chiao-Hsiung Chuang; Tien-Yu Huang; Horng-Yuan Wang; Shu-Chen Wei; Jau-Min Wong
Journal:  Intest Res       Date:  2017-10-23

Review 5.  Hypersensitivity Reactions to Biologicals: from Bench to Bedside.

Authors:  Aysegul Akarsu; Ozge Soyer; Bulent Enis Sekerel
Journal:  Curr Treat Options Allergy       Date:  2020-01-18

6.  Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma.

Authors:  Ajai Chari; Sagar Lonial; Tomer M Mark; Amrita Y Krishnan; Keith E Stockerl-Goldstein; Saad Z Usmani; Anil Londhe; Delores Etheredge; Sarah Fleming; Baolian Liu; Jon Ukropec; Thomas S Lin; Sundar Jagannath; Ajay K Nooka
Journal:  Cancer       Date:  2018-11-05       Impact factor: 6.860

Review 7.  Hypersensitivity Reactions to Monoclonal Antibodies in Children.

Authors:  Francesca Mori; Francesca Saretta; Annamaria Bianchi; Giuseppe Crisafulli; Silvia Caimmi; Lucia Liotti; Paolo Bottau; Fabrizio Franceschini; Claudia Paglialunga; Giampaolo Ricci; Angelica Santoro; Carlo Caffarelli
Journal:  Medicina (Kaunas)       Date:  2020-05-12       Impact factor: 2.430

Review 8.  Desensitization to biological agents used in rheumatology.

Authors:  Joanna Makowska; Anna Lewandowska-Polak
Journal:  Reumatologia       Date:  2020-02-28

Review 9.  Hypersensitivity reactions to monoclonal antibodies: Classification and treatment approach (Review).

Authors:  Irena Pintea; Carina Petricau; Dinu Dumitrascu; Adriana Muntean; Daniel Constantin Branisteanu; Daciana Elena Branisteanu; Diana Deleanu
Journal:  Exp Ther Med       Date:  2021-07-03       Impact factor: 2.447
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.